![William A. Goddard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William A. Goddard is the founder of Allozyne, Inc., founded in 2004.
Dr. Goddard is the founder of Schrödinger, Inc., founded in 1990.
Dr. Goddard is the founder of Systine, Inc., founded in 2001.
Dr. Goddard is the founder of Eidogen, Inc., founded in 2000.
Dr. Goddard is the founder of Switch Therapeutics, Inc., founded in 2020.
| Sociétés | Poste | Fin |
|---|---|---|
Switch Therapeutics, Inc.
 Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops precision RNA interference medicines for central nervous system diseases | Fondateur | - |
Eidogen, Inc.
 Eidogen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery services | Fondateur | - |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Fondateur | - |
| SCHRÖDINGER, INC. | Fondateur | - |
Systine, Inc.
 Systine, Inc. SemiconductorsElectronic Technology Designs, manufactures, sells, and services semiconductor front end processing equipment | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Allozyne, Inc.
Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Systine, Inc.
Systine, Inc. SemiconductorsElectronic Technology Designs, manufactures, sells, and services semiconductor front end processing equipment | Electronic Technology |
Eidogen, Inc.
Eidogen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery services | Commercial Services |
Switch Therapeutics, Inc.
Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops precision RNA interference medicines for central nervous system diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
